PATENT CLAIM ANALYSIS

Application Number: 15897796
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["544", "106000"]

Abstract:
Provided herein are compounds and compositions useful in increasing PPARδ activity. The compounds and compositions provided herein are useful for the treatment of PPARδ related diseases (e.g., muscular diseases, vascular disease, demyelinating disease, and metabolic diseases).

Claim (Index 9):
The compound of  claim 1 , wherein each R 2  independently is Cl, F, I, Br, cyano, NO 2 , or OH.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.51724
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14874008', '15482385', '15517893', '15766455', '11502456']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.834221686715599
- 35 USC 102 Novelty (BERT): 0.6126923751839785
- Combined Prediction Score: 0.812068755562437
- Mean Citation Score: 478.44763200000006
- Max Citation Score: 714.689
- Similarity Product: 476.31583222973336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test